Recent advances in the treatment of lupus nephritis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical and Experimental Nephrology

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10157-011-0556-4PMID 22057583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians

  2011cited by this paper
• Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.

  2010cited by this paper
• Practice pattern variation in oral glucocorticoid therapy after the induction of response in proliferative lupus nephritis

  2010cited by this paper
• Biologics in the treatment of systemic lupus erythematosus

  2010cited by this paper
• Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.

  2010cited by this paper
• Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus.

  2010cited by this paper
• Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis.

  2010cited by this paper
• Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study

  2010cited by this paper
• Belimumab for the treatment of systemic lupus erythematosus

  2010cited by this paper
• Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis

  2010cited by this paper
• Safety and potential efficacy of tacrolimus for treatment of lupus nephritis with persistent proteinuria

  2010cited by this paper
• Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis

  2010cited by this paper
• Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients.

  2010cited by this paper
• Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions

  2010influential reference
• Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis

  2010cited by this paper
• Use of methotrexate in patients with systemic lupus erythematosus and primary Sjögren's syndrome.

  2010cited by this paper
• Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

  2010cited by this paper
• Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

  2009cited by this paper
• Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.

  2009cited by this paper
• Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

  2009cited by this paper
• Biologics as treatment for systemic lupus: great efforts, sobering results, new challenges.

  2009cited by this paper
• Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.

  2009cited by this paper
• Clinical Assessment of Tacrolimus Therapy in Lupus Nephritis: One-Year Follow-Up Study in a Single Center

  2009cited by this paper
• Antiproteinuric Effect of Angiotensinconverting Enzyme Inhibitors and an Angiotensin II Receptor Blocker in Patients with Lupus Nephritis

  2009cited by this paper
• The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

  2009cited by this paper
• Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study

  2009cited by this paper
• Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases

  2009cited by this paper
• Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.

  2008cited by this paper
• Intravenous methylprednisolone or plasma exchange for adjunctive therapy of severe renal vasculitis?

  2008cited by this paper
• The role of aldosterone blockade in murine lupus nephritis

  2008cited by this paper
• B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.

  2008cited by this paper
• Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort.

  2008cited by this paper
• The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years.

  2007cited by this paper
• B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response

  2007cited by this paper
• Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations.

  2007cited by this paper
• Human clinical trials in lupus nephritis.

  2007cited by this paper
• Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.

  2007cited by this paper
• The renin-angiotensin system in lupus: physiology, genes and practice, in animals and humans

  2006cited by this paper
• High‐dose mizoribine treatment for adolescents with systemic lupus erythematosus

  2006cited by this paper
• Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis

  2006cited by this paper
• Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria

  2005cited by this paper
• Block and tackle: CTLA4Ig takes on lupus

  2005cited by this paper
• Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

  2005cited by this paper
• Cyclophosphamide in lupus nephritis

  2005cited by this paper
• Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.

  2005cited by this paper
• Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study.

  2005cited by this paper
• Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.

  2005cited by this paper
• Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus.

  2004cited by this paper
• The classification of glomerulonephritis in systemic lupus erythematosus revisited.

  2004influential reference
• An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.

  2004cited by this paper
• Sequential therapies for proliferative lupus nephritis.

  2004cited by this paper
• The classification of glomerulonephritis in systemic lupus erythematosus revisited.

  2004cited by this paper
• Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.

  2004cited by this paper
• K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

  2004cited by this paper
• An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritis

  2004cited by this paper
• K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

  2004cited by this paper
• Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients

  2003cited by this paper
• Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.

  2002cited by this paper
• Minimal change disease in systemic lupus erythematosus.

  2002cited by this paper
• Methotrexate therapy in systemic lupus erythematosus

  2001cited by this paper
• Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus Nephritis

  2001cited by this paper
• Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis.

  2001influential reference
• Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis

  2000cited by this paper
• Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.

  2000cited by this paper
• Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group.

  1996cited by this paper
• Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis

  1996cited by this paper
• Antibody depletion and cytotoxic drug therapy in severe systemic lupus erythematosus

  1992cited by this paper
• A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

  1992cited by this paper
• Randomised trial of plasma exchange in mild systemic lupus erythematosus.

  1983cited by this paper

• Treatment Outcomes of Proliferative vs. Non-proliferative Adult Lupus Nephritis: A 10-Year Follow-Up

  2021cites this paper
• Treatment of Lupus Nephritis from Iranian Traditional Medicine and Modern Medicine Points of View: A Comparative Study

  2021cites this paper
• Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide

  2020cites this paper
• The preliminary efficacy evaluation of the CTLA-4-Ig treatment against Lupus nephritis through in-silico analyses.

  2019cites this paper
• The role of miR-146b-5p in TLR4 pathway of glomerular mesangial cells with lupus nephritis.

  2018cites this paper
• Long-Term Outcome of 102 Cases of Lupus Nephritis: A Single-Center Cohort Study in Japan

  2017cites this paper
• Lupus nephritis: an update

  2016cites this paper
• Hypertensive Emergency in Adolescent with Systemic Lupus Erythematosus at Onset: A Case Report

  2016cites this paper
• Lupus nephritis: a nursing perspective

  2015influential citation
• Metabolomics Study on the Effects of Jieduquyuziyin Prescription on Systemic Lupus Erythematosus Mice by LC-Q-TOF/MS

  2013cites this paper
• The impact of the ISN/RPS classification of glomerulonephritis in systemic lupus erythematosus on the histological diagnosis of focal and diffuse lupus nephritis

  2013cites this paper
• The Autoimmune Tautology: From Polyautoimmunity and Familial Autoimmunity to the Autoimmune Genes

  2012cites this paper
• Scleroderma renal crisis precipitated by steroid treatment in systemic lupus erythematosus and scleroderma overlap syndrome.

  2012cites this paper
• Lupus nephritis: a critical review.

  2012cites this paper
• Lupus Nephritis: An Overview of Recent Findings

  2012cites this paper